2 active warrant series covering 29,632,267 shares (~11.6% potential dilution); nearest expiry 2027-10-08.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| finder | $0.10 | Oct 8, 2027 373d | 153K | OTM | 0.1% | C$15K | Auto |
| warrant | $0.10 | Oct 8, 2027 373d | 29.5M | OTM | 11.6% | C$2.9M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
1 option grant covering 20,000,000 shares (~7.8% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.12 | Jun 30, 2031* 1734d | 20.0M | OTM | 7.8% | C$2.4M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
254,954,066 shares outstanding, plus 29,632,267 from warrants and 20,000,000 from options — a fully diluted 304,586,333 shares, or ~19.5% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
2 active warrant series covering 29,632,267 shares (~11.6% potential dilution); nearest expiry 2027-10-08.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| finder | $0.10 | Oct 8, 2027 373d | 153K | OTM | 0.1% | C$15K | Auto |
| warrant | $0.10 | Oct 8, 2027 373d | 29.5M | OTM | 11.6% | C$2.9M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
1 option grant covering 20,000,000 shares (~7.8% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.12 | Jun 30, 2031* 1734d | 20.0M | OTM | 7.8% | C$2.4M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
254,954,066 shares outstanding, plus 29,632,267 from warrants and 20,000,000 from options — a fully diluted 304,586,333 shares, or ~19.5% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
